D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -37.88% -3.40% 50.15% -102.84% -6.61%
Total Depreciation and Amortization -26.61% -60.79% -16.80% -1.88% 18.27%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 173.22% 9.96% -66.70% 124.04% -261.64%
Change in Net Operating Assets 258.07% 138.37% -340.88% 240.25% 609.70%
Cash from Operations 7.34% 27.47% 29.11% -21.75% -57.53%
Capital Expenditure -- -- 18.41% -17.58% -131.28%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -53.88% 114.96% -- -- --
Cash from Investing -53.67% 114.90% 13,841.97% -2,718.09% 49,522.03%
Total Debt Issued -- -- -32.57% -- --
Total Debt Repaid 31.11% 30.52% 4.63% -354.87% 30.65%
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 45.86% 55.88% -99.68% -380.47% 11.76%
Foreign Exchange rate Adjustments 533.92% 250.18% -1,695.03% -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -160.72% 92.34% -100.50% -50.89% 160.70%